Chemours
507 hedge funds and large institutions have $3.81B invested in Chemours in 2018 Q4 according to their latest regulatory filings, with 87 funds opening new positions, 137 increasing their positions, 173 reducing their positions, and 127 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 6 → 9 (+3)
41% more call options, than puts
Call options by funds: $26.4M | Put options by funds: $18.8M
1.76% more ownership
Funds ownership: 76.96% → 78.72% (+1.8%)
8% less funds holding
Funds holding: 551 → 507 (-44)
21% less repeat investments, than reductions
Existing positions increased: 137 | Existing positions reduced: 173
30% less capital invested
Capital invested by funds: $5.42B → $3.81B (-$1.61B)
31% less first-time investments, than exits
New positions opened: 87 | Existing positions closed: 127
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCIM
TIAA CREF Investment Management
New York
|
+$62.6M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$56M |
| 3 |
LSV Asset Management
Chicago,
Illinois
|
+$35.6M |
| 4 |
Bank of New York Mellon
New York
|
+$27.2M |
| 5 |
LM
Luminus Management
Houston,
Texas
|
+$24M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$63.8M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$55.1M |
| 3 |
Prudential Financial
Newark,
New Jersey
|
-$48.3M |
| 4 |
AAM
Ardevora Asset Management
London,
United Kingdom
|
-$35.5M |
| 5 |
GCM
Gates Capital Management
New York
|
-$28.9M |
CC Hedge Fund Activity: Q4 2018 in Review
507 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q4 2018, worth a combined $3.81B — down 30% from $5.42B a quarter earlier.
Sellers outnumbered buyers: 127 funds closed out of CC and 87 opened new positions — a net loss of 40 holders — while 173 trimmed existing stakes and 137 added.
The largest buyer was TIAA CREF Investment Management, adding an estimated $62.6M. The largest seller was Fidelity Investments, cutting an estimated $63.8M.
- 507 institutional investors held Chemours (CC) as of Q4 2018, down from 551 in Q3 2018.
- Funds reported $3.81B of Chemours stock for Q4 2018, down 30% quarter-over-quarter.
- 87 funds opened new Chemours positions in Q4 2018 and 127 closed out, a net change of -40 holders.
- The largest Chemours buyer in Q4 2018 was TIAA CREF Investment Management, an estimated $62.6M added.
- The largest Chemours seller in Q4 2018 was Fidelity Investments, an estimated $63.8M sold.
Based on aggregated 13F filings for Q4 2018.